Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Popper

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Pathology|June 25, 2019
Prognostic value of cyclin A2 and B1 expression in lung carcinoidsLuka Brcic, Martin Heidinger, Anita Zenko Sever, et al.
Wiener Klinische Wochenschrift|September 14, 2016
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG)Christian Geltner, Peter Errhalt, Bernhard Baumgartner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Lung Cancer in AustriaRobert Pirker, Helmut Prosch, Helmut Popper, et al.
Free Radical Biology & Medicine|March 7, 2012
Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca²⁺-dependent induction of oxidative stressSlaven Crnkovic, Monika Riederer, Margarete Lechleitner, et al.
Archives of Pathology & Laboratory Medicine|August 31, 2016
Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a CritiqueVictor Roggli, Allen R Gibbs, Richard Attanoos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2013
Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesotheliomaFabian Mairinger, Claudia Vollbrecht, Iris Halbwedl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutationsThomas Wiesner, Isabella Fried, Peter Ulz, et al.
Histopathology|February 17, 2025
Comparative performance of PD-L1 scoring by pathologists and AI algorithmsMarkus Plass, Gheorghe-Emilian Olteanu, Sanja Dacic, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Pathology|June 25, 2019
Prognostic value of cyclin A2 and B1 expression in lung carcinoidsLuka Brcic, Martin Heidinger, Anita Zenko Sever, et al.
Wiener Klinische Wochenschrift|September 14, 2016
Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG)Christian Geltner, Peter Errhalt, Bernhard Baumgartner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 26, 2021
Lung Cancer in AustriaRobert Pirker, Helmut Prosch, Helmut Popper, et al.
Free Radical Biology & Medicine|March 7, 2012
Docosahexaenoic acid-induced unfolded protein response, cell cycle arrest, and apoptosis in vascular smooth muscle cells are triggered by Ca²⁺-dependent induction of oxidative stressSlaven Crnkovic, Monika Riederer, Margarete Lechleitner, et al.
Archives of Pathology & Laboratory Medicine|August 31, 2016
Pathology of Asbestosis: An Update of the Diagnostic Criteria Response to a CritiqueVictor Roggli, Allen R Gibbs, Richard Attanoos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2013
Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesotheliomaFabian Mairinger, Claudia Vollbrecht, Iris Halbwedl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2012
Toward an improved definition of the tumor spectrum associated with BAP1 germline mutationsThomas Wiesner, Isabella Fried, Peter Ulz, et al.
Histopathology|February 17, 2025
Comparative performance of PD-L1 scoring by pathologists and AI algorithmsMarkus Plass, Gheorghe-Emilian Olteanu, Sanja Dacic, et al.
Lung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
Pageof 7